RLMD
#3058
Relmada Therapeutics, Inc. - Common Stock
3.5 1 USD
+0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.54%
Monthly Change
-22.52%
6 month change
-51.85%
Year Change
+71.22%
Previous Close
3.3 9
Open
3.3 9
Low
3.3 2
High
3.5 3
Financials
2022
Current report, 13 Oct 2022
RELMADA THERAPEUTICS, INC. current report, 13 October 2022
8-K
Quarterly report, Q3 FY2022
RELMADA THERAPEUTICS, INC. quarterly report, Q3 FY2022
10-Q
Current report, 21 Sep 2022
RELMADA THERAPEUTICS, INC. current report, 21 September 2022
8-K
Current report, 20 Sep 2022
RELMADA THERAPEUTICS, INC. current report, 20 September 2022
8-K
Quarterly report, Q2 FY2022
RELMADA THERAPEUTICS, INC. quarterly report, Q2 FY2022
10-Q
Current report, 25 May 2022
RELMADA THERAPEUTICS, INC. current report, 25 May 2022
8-K
Current report, 05 May 2022
RELMADA THERAPEUTICS, INC. current report, 05 May 2022
8-K
Quarterly report, Q1 FY2022
RELMADA THERAPEUTICS, INC. quarterly report, Q1 FY2022
10-Q
Current report, 23 Mar 2022
RELMADA THERAPEUTICS, INC. current report, 23 March 2022
8-K
Current report, 07 Mar 2022
RELMADA THERAPEUTICS, INC. current report, 07 March 2022
8-K